Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $13.36 in the prior trading day, Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $12.53, down -6.21%. In other words, the price has decreased by -$6.21 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
Our goal is to gain a better understanding of CNTA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.37 and its Current Ratio is at 14.37. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on May 28, 2025, initiated with a Buy rating and assigned the stock a target price of $35.
On May 08, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $30.
On March 31, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $38.Piper Sandler initiated its Overweight rating on March 31, 2025, with a $38 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 27 ’25 when Weinhoff Gregory M sold 10,000 shares for $12.82 per share. The transaction valued at 128,225 led to the insider holds 122,279 shares of the business.
Weinhoff Gregory M bought 10,000 shares of CNTA for $128,225 on May 27 ’25. On May 20 ’25, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $12.71 each. As a result, the insider received 699,110 and left with 221,017 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 111.12 while its Price-to-Book (P/B) ratio in mrq is 4.33.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $7.90. The 50-Day Moving Average of the stock is -2.77%, while the 200-Day Moving Average is calculated to be -18.14%.
Shares Statistics:
A total of 133.55M shares are outstanding, with a floating share count of 84.83M. Insiders hold about 36.48% of the company’s shares, while institutions hold 57.67% stake in the company.
